Slice of Healthcare Team
11/03/2025
Key highlights
Source: PR Newswire
Notable Quotes
“ We are very pleased with the final national coverage determination, which opens up patient access to renal denervation with the Symplicity Spyral RDN system. ”
Jason Weidman, Senior VP at Medtronic
“ This determination represents a significant opportunity to improve care for patients and opens a novel and meaningful market for Medtronic. ”
Skip Kiil, EVP at Medtronic
Why this matters
This announcement marks a pivotal moment in hypertension management, providing Medicare patients with access to a groundbreaking treatment option that can significantly improve health outcomes for those struggling with uncontrolled high blood pressure. This development is particularly significant for the healthcare sector.
Keep reading
